What is Abrexa Pharmaceuticals worth?
$75.5Mlast known valuation
Abrexa Pharmaceuticals last raised $23.0M in its Early Stage VC (Apr 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Abrexa Pharmaceuticals
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Apr 2025 | Early Stage VC | $23.0M | ▮ | ▮ |
| Jul 2018 | Early Stage VC | $16.6M | ▮ | ▮ |
How Abrexa Pharmaceuticals's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Abrexa Pharmaceuticals, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Abrexa Pharmaceuticals worth?
- Abrexa Pharmaceuticals's last known valuation is $75.5M.
- How much has Abrexa Pharmaceuticals raised?
- Abrexa Pharmaceuticals has raised $40.1M in total funding across 2 recorded rounds.
- When did Abrexa Pharmaceuticals last raise?
- Abrexa Pharmaceuticals last raised in Apr 2025 (Early Stage VC), raising $23.0M.